Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
IITZ-01
Cat. No.:
OB0225LY-0420
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
IITZ-01 is high-quality autophagy inhibitor with single-agent anticancer activity.
Synonym:
1807988-47-1; N2-(4-(1H-Benzo[d]imidazol-2-yl)phenyl)-N4-(4-fluorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine; 4-N-[4-(1H-Benzimidazol-2-yl)phenyl]-2-N-(4-fluorophenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine
CAS No.:
1807988-47-1
Compound CID:
134817273
Formula:
C26H23FN8O
Formula Weight:
482.51
Specification
Relative Density:
1.420 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
IITZ-01 can be used in the development of new drugs or play an important role in cell biology research.
Library Information
Targets:
PI3K
Receptors:
PI3Kγ
Pathways:
Apoptosis; Autophagy; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-6
Plate Location:
d6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
150 mg/mL; 310.87 mM
